COMPANY

Quetzal Therapeutics

HQ: Chicago, IL source · quetzaltx.com ↗

Keywords: rare disease rare diseases oncology acute promyelocytic leukemia hematology hematologic malignancies Acute Promyelocytic Leukaemia Acute Promyelocytic Leukemia With PML-RARA

Location: Chicago, IL · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

Jun 8, 2026 Trial start 3: Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia source ↗

Upcoming milestones

2027-03 (ESTIMATED) · 3 · Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia · NCT07504458

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07504458	Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia	3	Recruiting	Jun 8, 2026	2027-03 (estimated)